Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01573871 · ClinicalTrials.gov registry record · Phase 3
Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT01573871 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 25 participants.
The verdict
NCT01573871, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
The objective of the study is to assess gastrointestinal tolerance and compliance in infants who require a hydrolyzed formula.
Interventions
- OTHER Experimental Hydrolyzed infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01573871
The ClinicalTrials.gov registry entry for NCT01573871 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Experimental Hydrolyzed infant formula is the first listed.
NCT01573871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01573871 about?
NCT01573871 is a clinical study titled "Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula". The objective of the study is to assess gastrointestinal tolerance and compliance in infants who require a hydrolyzed formula.
What is the current status of trial NCT01573871?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2012-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01573871?
The interventions under investigation include: Experimental Hydrolyzed infant formula (OTHER).
Who is sponsoring clinical trial NCT01573871?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.